Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
暂无分享，去创建一个
Patrick B. Schwartz | Hong-Jin Kim | Robert C. G. Martin | S. Maithel | N. Merchant | C. Scoggins | D. Abbott | R. Fields | S. Weber | Syed A. Ahmad | A. Livingstone | D. Kooby | W. Hawkins | Sameer H. Patel | Rachel M. Lee | Gregory A Williams | V. Dudeja | D. Franceschi | E. Ryon | U. Maduekwe | F. Macedo | S. Patel